Published in Thromb Haemost on December 15, 1986
The neuropathology of fatal cerebral malaria in malawian children. Am J Pathol (2011) 1.79
Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1990) 1.54
Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1992) 1.16
Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest (1993) 0.98
Interferon-γ and tumor necrosis factor-α act synergistically to up-regulate tissue factor in alveolar epithelial cells. Exp Lung Res (2011) 0.81
An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods (1974) 6.54
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest (1978) 5.80
Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med (1982) 3.82
Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med (1984) 2.52
Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N Engl J Med (1980) 2.41
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Determinants of sickness in marine recruits. Am J Epidemiol (1969) 2.01
Plasma exchange in the treatment of immune disease. Transfusion (1976) 1.81
Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R (1990) 1.79
Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol (1974) 1.59
Hydrogen peroxide alters signal transduction in human endothelial cells. J Lab Clin Med (1991) 1.57
Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study. Ann Intern Med (1989) 1.46
Deleterious effects of endotoxin on cultured endothelial cells: an in vitro model of vascular injury. Inflammation (1981) 1.40
Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol (1976) 1.40
Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol (1974) 1.39
Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol (1990) 1.38
Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage. Semin Hematol (1979) 1.33
Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. Am J Pathol (1974) 1.27
Cryoglobulinemia in infectious mononucleosis: quantitation and characterization of the cryoproeins. J Lab Clin Med (1968) 1.23
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med (1980) 1.23
Mechanism of tissue factor activation on HL-60 cells. Blood (1997) 1.23
Frequent association of IgMlambda with crystalline inclusions in chronic lymphatic leukemic lymphocytes. N Engl J Med (1973) 1.20
Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest (1996) 1.19
Influence of epinephrine on the aggregation response of aspirin-treated platelets. Prostaglandins Med (1980) 1.18
Antinuclear antibodies in infectious mononucleosis. Lancet (1968) 1.17
Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci U S A (1990) 1.14
Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol (1975) 1.12
Immunochemical studies on blood groups. XXXIII. The effects. of alkaline borohydride and of alkali on blood group A, B, and H substances. Biochemistry (1965) 1.12
Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: role of red cell glutathione. Science (1985) 1.12
Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc Natl Acad Sci U S A (1982) 1.10
Studies on human antibodies. IV. Purification and properties of anti-A and anti-B obtained by absorption and elution from insoluble blood group substances. J Exp Med (1966) 1.09
Measurement of ionized calcium in blood platelets with a new generation calcium indicator. Biochem Biophys Res Commun (1985) 1.07
An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. Am J Pathol (1978) 1.07
Human monocyte and macrophage modulation of lymphocyte proliferation. Cell Immunol (1979) 1.07
Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma. Cancer Genet Cytogenet (1984) 1.06
Cell-cell interaction in erythropoiesis. Role of human monocytes. J Clin Invest (1978) 1.06
Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials (2000) 1.06
From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Semin Hematol (1997) 1.05
Labile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal platelets. Br J Haematol (1975) 1.05
Influence of the ionophore A23187 on the plastic behavior of normal erythrocytes. Am J Pathol (1977) 1.03
Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells. Br J Haematol (1987) 1.03
Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. Am J Pathol (1978) 1.03
Complement-dependent opsonization of incompatible erythrocytes by human secretory IgA. J Immunol (1972) 1.02
Folate-induced remission in aplastic anemia with familial defect of cellular folate uptake. N Engl J Med (1978) 1.02
Hemoglobin Andrew-Minneapolis alpha 2 A beta 2 144 Lys leads to Asn: a new high-oxygen-affinity mutant human hemoglobin. Blood (1974) 1.00
Surface-activated bovine platelets do not spread, they unfold. Am J Pathol (1990) 0.99
Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol (1998) 0.99
Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res (1986) 0.99
Red-cell-membrane polypeptide aggregates in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease. A clue to the mechanism of hemolysis. N Engl J Med (1979) 0.98
Effects of a microtubule stabilizing agent on the response of platelets to vincristine. Blood (1982) 0.97
Membrane polypeptide aggregates in glucose 6-phosphate dehydrogenase-deficient and in vitro aged red blood cells. J Lab Clin Med (1978) 0.97
Modulation of erythrocyte-endothelial interactions and the vasocclusive severity of sickling disorders. Blood (1981) 0.96
Recycling of platelet phosphorylation and cytoskeletal assembly. J Cell Biol (1984) 0.96
Heterogeneity among human lymphocyte effector cells mediating spontaneous lymphocyte-mediated cytotoxicity. Int J Cancer (1978) 0.95
Maternal and paternal lineages of the Samaritan isolate: mutation rates and time to most recent common male ancestor. Ann Hum Genet (2003) 0.95
Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium. J Exp Med (1993) 0.94
Structural features of endotoxin required for stimulation of endothelial cell tissue factor production; exposure of preformed tissue factor after oxidant-mediated endothelial cell injury. J Lab Clin Med (1985) 0.94
In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. Br J Haematol (1982) 0.94
The population of paroxysmal nocturnal hemoglobinuria neutrophils deficient in decay-accelerating factor is also deficient in alkaline phosphatase. Blood (1988) 0.94
Influence of a microtubule stabilizing agent on platelet structural physiology. Am J Pathol (1983) 0.93
Human monocyte-induced tumor cell cytotoxicity. Blood (1978) 0.93
Characterization and comparison of human monocyte- and macrophage-induced tumor cell cytotoxicity. J Lab Clin Med (1979) 0.93
Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun (1983) 0.92
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis (1983) 0.91
Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci U S A (1986) 0.90
Inflamed fibronectin: an altered fibronectin enhances neutrophil adhesion. Blood (1983) 0.90
Endothelial cell heterogeneity: antioxidant profiles determine vulnerability to oxidant injury. Proc Soc Exp Biol Med (1988) 0.90
Arachidonate-induced platelet aggregation in the dog. Thromb Res (1979) 0.90
Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets. Am J Hematol (1981) 0.90
Antisterility and antivitamin K activity of d-alpha-tocopheryl hydroquinone in the vitamin E-deficient female rat. J Nutr (1975) 0.89
An improved method for the extraction of endogenous platelet serotonin. J Lab Clin Med (1976) 0.89
Enkephalins modify granulocyte-endothelial interactions by stimulating prostacyclin production. Thromb Haemost (1983) 0.89
Catecholamine hormone receptors are reduced on chronic lymphocytic leukaemic lymphocytes. Nature (1977) 0.88
Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. Biochim Biophys Acta (1982) 0.88
The influence of glutathione depleting agents on human platelet function. Thromb Res (1989) 0.87
Type-C and type-D primate retrovirus envelope glycoproteins bind common cellular receptor sites. Virology (1979) 0.87
Training internal medicine residents in the community: the Minnesota experience. Acad Med (1995) 0.87
Leukocytosis and large cell lung cancer. A frequent association. Cancer (1987) 0.87
Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J Lab Clin Med (1995) 0.86
The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am J Pathol (1977) 0.86
Familial Hodgkin's disease and the major histocompatibility complex. Vox Sang (1977) 0.85
Immune mechanisms for destruction of erythrocytes in vivo. I. The effect of IgG rabbit antibodies on rat erythrocytes. Transfusion (1967) 0.85
Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia. Cancer Treat Rep (1979) 0.85
Serum anti-gamma-G globulin factors in paroxysmal nocturnal hemoglobinuria. Blood (1966) 0.84
Cryptococcal meningitis with false-positive cytology in the CSF. Use of T-cell rosetting to exclude meningeal lymphoma. JAMA (1978) 0.84
Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol (1978) 0.84
Modification of human platelet response to sodium arachidonate by membrane modulation. Prostaglandins Med (1981) 0.83
Treatment of polycythemia vera with hydroxyurea. Am J Hematol (1984) 0.83
Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells. Lab Invest (1993) 0.83
Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function. Biochim Biophys Acta (1980) 0.83
Cell-cell interaction in erythropoiesis. Prog Hematol (1979) 0.83
Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesis. Prostaglandins Med (1978) 0.83
Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function. Prostaglandins Med (1980) 0.82
Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif Organs (1999) 0.82
Avian tumor virus interactions with chicken fibroblast plasma membranes. J Supramol Struct (1976) 0.82
5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J Microencapsul (2001) 0.82
Glutathione levels in human platelets display a circadian rhythm in vitro. Thromb Res (1985) 0.82